Capsule endoscopy market seen reaching $1.26 billion by 2030

The capsule endoscopy market is projected to grow from $0.84 billion in 2026 to $1.26 billion by 2030, driven by rising gastrointestinal disease, healthcare spending and adoption of AI-enabled diagnostics. North America led the market in 2025, while Asia-Pacific and other regions are expected to add more growth as access to advanced diagnostics expands.

Why it matters: - Capsule endoscopy gives clinicians a minimally invasive way to inspect the gastrointestinal tract and detect conditions such as bleeding, ulcers and inflammatory bowel disease. - The market’s growth reflects broader demand for earlier diagnosis, non-invasive testing and digital diagnostic tools. - The category is moving from a niche imaging option to a more central tool for GI evaluation as health systems expand diagnostic capacity.

What happened: - The Business Research Company said the global capsule endoscopy market is expected to rise from $0.76 billion in 2025 to $0.84 billion in 2026. - The report forecasts the market will reach $1.26 billion by 2030. - The company released its 2026 market outlook report covering size, trends, segments and global forecasts. - The report is available through a free sample request and a full market report.

The details: - The report pegs 2025-2026 growth at a 11.0% CAGR. - It projects 2026-2030 growth at a 10.6% CAGR. - Key historical growth drivers include more gastrointestinal disorders, limitations of traditional endoscopy, rising preference for non-invasive diagnostics, expansion of hospital diagnostic services and better capsule imaging technology. - Forecast growth is linked to earlier disease detection, wider use of AI-powered diagnostic tools, growth in outpatient diagnostic centers, higher investment in digital health platforms and stronger patient-centered diagnostics. - Emerging trends include wireless capsule imaging systems, AI-assisted image analysis, specialized capsule applications and tighter integration with software diagnostic platforms. - Capsule endoscopy uses a small pill-sized camera that patients swallow to capture images of the GI tract. - The technology helps identify bleeding, ulcers and inflammatory bowel diseases, including areas that are hard to examine with conventional endoscopy. - Rising gastrointestinal disease burden is a major demand driver. - The UK-based IBD Registry reported in December 2023 that IBD patient numbers exceeded 5,300, up by more than 3,000 from 2022. - The report also points to higher healthcare spending as a market tailwind. - The Centers for Medicare & Medicaid Services said U.S. healthcare spending rose 7.5% in 2023 to $4.9 trillion, or about $14,570 per person. - North America held the largest share of the global market in 2025. - The report also covers Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The market is benefiting from a shift toward earlier, less invasive diagnosis across gastroenterology. - AI appears to be becoming a bigger part of capsule imaging workflows, which could improve speed and interpretation quality. - North America’s lead suggests strong current infrastructure, while faster future gains may come from regions still expanding access to advanced diagnostics. - The report’s emphasis on digital health platforms signals that software may matter as much as hardware in the next phase of market growth.

What's next: - The Business Research Company expects continued expansion through 2030 as outpatient care, AI tools and digital diagnostic systems gain wider use. - Emerging markets may contribute a larger share of incremental demand as healthcare systems modernize and diagnostic access improves. - The company’s 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards and hotspot infographics.

The bottom line: - Capsule endoscopy is evolving into a faster-growing diagnostic category as GI disease, digital health investment and AI-supported analysis push adoption higher.